$37.60 0.20 (+0.53%)
12/4/2009 11:45 AM

Eli Lilly & Co. (LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

2
Member Avatar bobbyvee (98.18) Submitted: 3/7/2009 11:48:54 AM : Underperform Start Price: $26.58 LLY Score: +23.81

Pharaceuticals will suffer under this administration's plan for universal care

Report this Post 1 Comment
Member Avatar wrparks (62.99) Submitted: 6/2/2009 9:15:16 AM
Recs: 2 Rec This

I disagree. I think their margins may be squeezed due to lower drug prices. But, I expect their volume may increase offsetting this. I'm not highly confident they will outperform, but I don't think your explanation is a very good one.

Report this Post

Featured Broker Partners